What is Retatrutide?
Retatrutide is a synthetic peptide compound classified as a triple receptor agonist.
It binds to and activates the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent
insulinotropic polypeptide), and Glucagon receptors simultaneously, enabling researchers
to study the combined downstream signalling effects of all three pathways in a single
experimental model.
Mechanism of Action
GLP-1 receptor activation modulates insulin secretion and inhibits glucagon release in
a glucose-dependent manner. GIP receptor activation potentiates insulin response and
influences lipid metabolism. Glucagon receptor activation regulates hepatic glucose output
and energy expenditure. Retatrutide's simultaneous engagement of all three receptors
produces an additive effect on metabolic regulation pathways, making it a valuable tool
for multi-receptor research.
Research Applications
This compound is suitable for in vitro binding assays, receptor activation studies,
metabolic pathway analysis, and comparative pharmacology research involving incretin and
glucagon receptor systems.
📋 Researcher Qualification & Compliance
This product is sold exclusively to qualified researchers, licensed institutions, and
certified laboratories. Purchasers are solely responsible for ensuring compliance with
all applicable national, regional, and local laws and regulations governing the
acquisition, handling, storage, and use of research compounds. SynedicaLabs assumes
no liability for misuse or use outside of a controlled research environment.
